← Leaderboards
Ronald Swensen
Fred Hutchinson Cancer Research Center
$621,328
Attributed
$1,863,983
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $437.7K · FY2009–13$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,863,983 · 1
By mechanism
P50$1,863,983 · 1
Top collaborators
- Mary L. Disis5 shared
- Lupe G Salazar5 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Margaret M Madeleine$13,649,862
- Patricia L Blount$6,306,969
- Garnet L. Anderson$31,358,530
- Ingegerd E. Hellstrom$2,606,811
- Amanda G Paulovich$38,180,578
Others in their field
Top investigators on “Active Immunization”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$466,593,725
- Judith S. Currier · University Of California Los Angeles$322,872,111
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$256,197,143
- Daniel R Kuritzkes · Brigham And Women'S Hospital$217,875,923
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
Research focus
Active ImmunizationAllelesAnimal ModelAdjuvantAntigen PresentationAntigen-Presenting CellsAntigensAvidityBaseBinding (Molecular Function)Cancer InvasivenessCancer PatientCancer RecurrenceCancer RelapseCd4 Positive T LymphocytesCd8b1 GeneCellsCytokineDesignDna VaccinesEnvironmentEpitopesFamilyHigh-Risk Cancer
Grant awards (5)
Vaccinating against IGFBP-2 to prevent ovarian cancer relapse$321,413
P50 · FY2013 · CA
Vaccinating against IGFBP-2 to prevent ovarian cancer relapse$347,224
P50 · FY2012 · CA
Vaccinating against IGFBP-2 to prevent ovarian cancer relapse$437,712
P50 · FY2011 · CA
Vaccinating against IGFBP-2 to prevent ovarian cancer relapse$369,911
P50 · FY2010 · CA
Vaccinating against IGFBP-2 to prevent ovarian cancer relapse$387,723
P50 · FY2009 · CA